These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Isolated liver and multivisceral transplantation for total parenteral nutrition-related end-stage liver disease. Nathan JD; Rudolph JA; Kocoshis SA; Alonso MH; Ryckman FC; Tiao GM J Pediatr Surg; 2007 Jan; 42(1):143-7. PubMed ID: 17208555 [TBL] [Abstract][Full Text] [Related]
32. [Hepatic and biliary complications during parenteral nutrition]. Bengoa J Rev Med Suisse Romande; 1984 Mar; 104(3):219-23. PubMed ID: 6426014 [No Abstract] [Full Text] [Related]
33. Effect of total parenteral nutrition on hepatic histology. Wolfe BM; Walker BK; Shaul DB; Wong L; Ruebner BH Arch Surg; 1988 Sep; 123(9):1084-90. PubMed ID: 3137913 [TBL] [Abstract][Full Text] [Related]
34. Postoperative jaundice. Koff RS Med Clin North Am; 1975 Jul; 59(4):823-9. PubMed ID: 1095844 [No Abstract] [Full Text] [Related]
35. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Meguid MM; Akahoshi MP; Jeffers S; Hayashi RJ; Hammond WG Arch Surg; 1984 Nov; 119(11):1294-8. PubMed ID: 6437372 [TBL] [Abstract][Full Text] [Related]
36. Total parenteral nutrition-induced steatosis: reversal by parenteral lipid infusion. Reif S; Tano M; Oliverio R; Young C; Rossi T JPEN J Parenter Enteral Nutr; 1991; 15(1):102-4. PubMed ID: 1901098 [TBL] [Abstract][Full Text] [Related]
37. Homocysteine prevents total parenteral nutrition (TPN)-induced cholestasis without changes in hepatic oxidative stress in the rat. Belli DC; Albrecht R; La Scala GC; Desjeux JF; Pelissier MA J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):200-5. PubMed ID: 12548054 [TBL] [Abstract][Full Text] [Related]
38. Cholestasis induced by total parenteral nutrition. Guglielmi FW; Regano N; Mazzuoli S; Fregnan S; Leogrande G; Guglielmi A; Merli M; Pironi L; Penco JM; Francavilla A Clin Liver Dis; 2008 Feb; 12(1):97-110, viii. PubMed ID: 18242499 [TBL] [Abstract][Full Text] [Related]
39. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition. Golucci APBS; Morcillo AM; Hortencio TDR; Ribeiro AF; Nogueira RJN Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791 [TBL] [Abstract][Full Text] [Related]
40. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]